Key Responsibilities:

• Represent PCS on Oncology project teams and ensure appropriate design, timing, and execution of nonclinical safety studies to meet team objectives.
• Oversee nonclinical strategy to enable initiation of clinical trials and achievement of registration for drug candidates. Collaborate with line functions outside of PCS to accomplish this goal
• Assemble and lead Target teams to ensure appropriate PCS input to project plans and appropriate resource planning within PCS
• Convey clear, concise and correct communication of nonclinical safety results and their impact to Health Authorities and investigators.
• Communicate to PCS and project teams regarding the theoretical or observed safety effects, their impact and proposed plans to address them.
• Partner with the PCS Therapeutic Area Head for alignment with PCS Therapeutic Area Strategy Teams, PCS line functions and BR/Novartis Development project/program teams in managing the preparation and presentation of nonclinical safety data in internal and external documents (e.g. Investigator’s Brochure, IND, CTD, IMPD, Health Authority briefing books) and in negotiation with Health Authorities.
• Evaluate in-licensing opportunities and participate in due diligence activities upon request.

Essential Requirements:

Education: PhD in Pharmacology, Toxicology or a related biological science. An MD/DVM/ PharmD or equivalent with a strong background or equivalent work experience may be considered.

• Demonstrated experience in the preclinical development of small molecule, biotherapeutics and/or gene and cell therapies and the safety issue awareness of these modalities
• 3 plus years experience in a nonclinical drug development scientific discipline (e.g. study director, project team toxicologist or pharmacologist) required
• Awareness of global health authority guidance and expectations for nonclinical programs supporting regulatory applications.
• Experience in direct or written communication of strategy and data to global health authorities.
• Excellent interpersonal, leadership, organizational skills (e.g. planning and time management) and teamwork skills.
• Ability to focus and work on several projects simultaneously and to effectively manage conflicting expectations from the line unit, TA Strategy team and project teams in a matrix management environment.
• Recognized ability to represent PCS on Novartis cross functional decision boards or other cross functional project teams.
• Recognized expertise in technical and scientific problem solving in a project driven, multi-disciplinary international environment.

Desirable Requirements:

• Oncology drug development experience, including therapeutic or diagnostic radiopharmaceuticals, would be preferred.

*****

Commitment to Diversity and Inclusion:

Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

Novartis Compensation and Benefit Summary: The pay range for this position at commencement of employment is expected to be between $151,200 and $226,800/year; however, while salary ranges are effective from 1/1/24 through 12/31/24, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills, and abilities. The total compensation package for this position may also include other elements, including a sign-on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered. Details of participation in these benefit plans will be provided if an employee receives an offer of employment. If hired, employee will be in an “at-will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.